|
Código del ensayo CARMAN |
|
Ensayo Early treatment intensification in patients with high risk mantle cell lymphoma using car-t-cell treatment after an abbreviated induction therapy with rituximab and ibrutinib and 6 months ibrutinib maintenance (arm a) as compared to standard of care induction and maintenance (arm b) |
|
Estado Abierto a inclusión |
|
Localización Tumoral Hematológicos |
|
Tipo de tumor Linfomas |
|
Tipo de ensayo Ensayo de Fase II |
|
Tipo de tratamiento |
|
Situación clínica |
|
Centro |
